REVG vs TECH · P/E 34, rev $2.38B vs P/E 65, rev $1.22B
Rev Group Inc (REVG) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Rev Group Inc (REVG) is a farm & heavy construction machinery company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported REVG revenue for 2024-10-31 was $2.38B. Net income was $257.6M. Revenue was down 9.8% from 2023-10-31 to 2024-10-31. REVG currently screens at market cap $3.12B and trailing P/E 33.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
REVG currently screens at market cap $3.12B and trailing P/E 33.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the REVG and TECH stock pages for the full models.
Not investment advice.